Bienvenue sur le forum TechNet

Cross-posted from the February 2012 Global Immunization News issue. Many thanks. 29/02/2012 from Jhilmil Bahl, WHO HQ As the introductions of Pneumo and Rota vaccines in 2012 are fast approaching, training materials are being developed at WHO/HQ. Rotarix materials will be available by mid-Ma...

by Darin Zehrung, Jean-Marie Préaud, and Emily Griswold, PATH In an effort to advance the development of promising new rotavirus vaccine candidates, PATH is assisting manufacturers in Brazil, China, and India in the formulation, manufacturing, and clinical development of the vaccine candidates. T...

In recent years, supply chain management has received growing attention as both a priority and a challenge for many countries scaling up immunization services with new vaccines. Indeed, the vaccine supply chain and logistics systems face the challenge to manage an increasing number of vaccines of hi...

Many thanks! A dozen updates this week as the new vaccine pledging meeting approaches. Will the funds pledged next month cover the needs for introduction of rotavirus, pneumococcal and HPV vaccines? ‘The doubt is permitted,’ as they say in French. Here are the titles of the new technical upda...

Written by: Madjiguène Ndiaye, SNEIPS; Ibrahima Leye, Consultant; and Mariama Gueye, PATH On October 27, 2010, the Government of Senegal officially launched a new project to demonstrate the impact of various changes and upgrades to the vaccine supply chain including the use of mobile warehouses to...

Call for Documents on the Effects of New Vaccine Introduction on National Immunization Programs and Health Systems Robert Steinglass and Mike Favin post this request. The USAID-funded MCHIP Project (Maternal and Child Health Implementation Project) would very much appreciate your assistance in...

James Cheyne shares with us the jointly produced (IFRC/GAVI Alliance) advocacy report on immunization, entitled "Unfinished business". The report was pre-released at the UN Palais in Geneva earlier this month and will be more formally launched at the forthcoming MDG Summit. The press re...

A recently published paper (JB Milstien and M Kaddar. 'The role of emerging manufacturers in access to innovative vaccines of public health importance', Vaccine 28: 2115-2121, 2010) analyzes the potential for emerging suppliers, those vaccine manufacturers located in developing countries, to supply ...

Utilizing new vaccine momentum and community engagement to strengthen pneumonia and diarrhoea control Today, pneumonia and diarrhoea remain the leading child-killers, especially in disadvantaged communities with limited access to sanitation, clean water, good nutrition and health services, and where...

The Advanced Immunization Management (AIM) e-Learning website launched a new module on 7 October to support the World Health Organization's computer-based Measles Strategic Planning (MSP) tool. The MSP was developed to help countries develop measles vaccination strategies to meet their measles contr...

Temperature Monitoring Study To Commence in Vietnam and Uganda by Joanie Robertson, Huong Vu and James Cheyne, PATH While some vaccines will lose their potency if they are stored at temperatures above or below the standard 2° to 8°C, many vaccines are quite heat stable and can tolerate temperatures...

Hello, With the advent of the new Pneumococcal and Rotavirus vaccines packaged in single dose pre-filled glass syringes, we are likely to be facing a complication in waste management. It's my understanding that this is likely to be a transitory trend for many of the new vaccines in the future, whic...

The Advanced Immunization Management (AIM) e-Learning website recently launched a new module to help decision-making on rotavirus vaccine introduction. The module provides comprehensive information from basic disease characteristics through immunization session planning; this interactive online to...

Public Sector and Industry: Working Together to Better Meet Developing Country Needsby Debra D. Kristensen, Senior Technical Officer and Policy Advisor, PATH, and Christopher B. Nelson, Senior Director, Medical Affairs and Policy, Merck & Co, Inc. Originally established in 2007 by the GAVI Allia...

A New, Comprehensive, Effective Vaccine Management Tool by Osman David Mansoor, Senior Advisor EPI, UNICEF; Hailu Kenea, Technical Officer EPI, WHO; and Andrew Garnett, PATH Consultant Following a consultative meeting held at the World Health Organization (WHO) in Geneva on March 9 & 10, 2009, W...

POST 01369E: NEW VACCINE INTRODUCTION—ROTAVIRUS 5 JANUARY 2009 ****************************************** Rotavirus is the leading cause of severe diarrhoea in young children worldwide and accounts for approximately 40 percent of diarrhoea-related hospitalizations. Use of rotavirus vaccines glo...

POST 01356E: VACCINE RESEARCH AND INTRODUCING NEW VACCINES 25 NOVEMBER 2008 ****************************************** A Boost for Vaccine Research: (Science, Emma Hitt: 28 March 2008) A recent estimate of the global vaccine business by Lehman Brothers predicts that the vaccine industry will...

POST 01292E: NEEDLE-FREE/COLD CHAIN-FREE VACCINE DELIVERY 20 JULY 2008 ******************************************* A peep into the future with regard to needle-free vaccine delivery reveals that innumerable innovative technologies are being researched to deliver vaccines. These range from aerosol...

POST 01210E : ROTAVIRUS VACCINE EFFICACY 29 December 2007 Here is an article published in the Lancet late November. It assesses the efficacy of the oral live attenuated human rotavirus vaccine Rotarix (RIX4414) for prevention of rotavirus gastroenteritis. You are reminded that you need to registe...

POST 01152E : REVISED WHO POSITION PAPER ON ROTAVIRUS VACCINES 2 September 2007 Please note that a revised WHO position paper on rotavirus vaccines has just been published in the WHO Weekly Epidemiological Record. The paper is available in English and French. It will shortly be translated into A...